In this video, Jennifer Chen from the Eisenbarth Lab in collaboration with Wilen lab at Yale University tells us their latest findings on different types of T- follicular helper cells and role in the context of infectious diseases.

Professor Akiko Iwasaki from Yale School of Medicine describes an efficient strategy called Prime and Boost to increase immune responses against Covid-19.

Professor Akiko Iwasaki from Yale University details her latest studies on the antibody response induction against latest Sars-CoV-II variants in the context of vaccination and the use of boosters. This is the first out of 2 interviews.

Dr. Vilas Navapurkar from Cambridge University Hospital NHS Foundation Trust describes his latest findings on the benefits of air filtration in clearing airborne pathogens including Sars-CoV-II.

Dr Rohit Jangra, Dr M. Eugenia Dieterle and Dr Denise Haslwanter from Albert Einstein College of Medicine describe their recent findings on the generation of recombinant virus that include SARS-CoV-2 spike protein to study viral entry and immune response in a BSL-2 facility. Read the full article at: https://pubmed.ncbi.nlm.nih.gov/32738193/

Dr Mannan Nouri from Harvard Medical School explains his findings regarding prostate cancer identifying a protein that may serve as a novel biomarker. Read the full paper at: https://clincancerres.aacrjournals.org/content/early/2020/01/09/1078-0432.CCR-19-0098?versioned=true

Summary of study by Maj et al in Nature Immunology where apoptosis of T-reg induce resistance to check-point inhibitors in cancer. Read the full article at: https://www.nature.com/articles/ni.3868

Dr. Nandini Acharya, from the Ohio State University Wexner Medical Center, tells us her latest findings regarding the role of glucocorticoid in the context of cancer, that she generated as a post-doc at Harvard Medical School.